Should PNPLA3 polymorphism be performed in clinical practice in patients with NAFLD to predict the risk of disease progression?

Hepatology. 2022 Nov;76(5):1246-1247. doi: 10.1002/hep.32510. Epub 2022 Apr 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Disease Progression
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Lipase / genetics
  • Non-alcoholic Fatty Liver Disease* / genetics
  • Polymorphism, Genetic
  • Polymorphism, Single Nucleotide

Substances

  • Lipase